Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Digestive Diseases and Sciences
Literature
1.
Hollander D. Intestinal absorption of vitamins A, E, D and K. J Lab Clin Med. 1981;97:449–462.PubMed
2.
The Goldsmith Family Foundation. Los Angeles, CA.
3.
Pearson AD, Eastman EJ, Laker MF, Craft AW, Nelson R. Intestinal permeability in children with Crohn’s disease and celiac disease. Br Med J. 1982;285:20–21.CrossRef
4.
Bjarnason I, O’Morain C, Levi AJ, Peters TJ. Absorption of 51-Chromium-labeled ethylenediaminetetracetate in inflammatory bowel disease. Gastroenterology. 1983;85:318–322.PubMed
5.
Ukabam SO, Clamp JR, Cooper BT. Abnormal small intestinal permeability to sugars in patients with Crohn’s disease of the terminal ileum and colon. Digestion. 1983;27:70–74.PubMedCrossRef
6.
Delahunty T, Hollander D. Liquid chromatographic method for estimating urinary sugars: applicability to studies of intestinal permeability. Clin Chem. 1986;32:1542–1544.PubMed
7.
Hollander D, Vadheim CM, Brettholz E, Peterson GM, Delahunty TJ, Rotter JI. Increased intestinal permeability in Crohn’s patients and their relatives: an etiological factor. Ann Int Med. 1986;105:883–885.PubMedCrossRef
8.
Buhner S, Buning C, Genschel J, et al. Genetic basis for increased intestinal permeability in families with Crohn’s disease: role of CARD 15 3020insC mutation? Gut. 2006;55:342–347.PubMedCrossRef
9.
Teshima CW, Dieleman LA, Meddings JB. Abnormal intestinal permeability in Crohn’s disease pathogenesis. Ann N Y Acad Sci. 2012;1258:159–165.PubMedCrossRef
10.
Irvine EJ, Marshall JK. Increased intestinal permeability precedes the onset of Crohn’s disease in a subject with familial risk. Gastroenterology. 2000;119:1740–1744.PubMedCrossRef
11.
D’Inca R, Annese V, di Leo V, et al. Increased intestinal permeability and NOD2 variants in familial and sporadic Crohn’s disease. Aliment Pharmocol Ther. 2006;23:1455–1461.CrossRef
12.
Suenaert P, Bulteel V, Lemmens L, et al. Anti-tumor necrosis factor treatment restores the gut barrier in Crohn’s disease. Am J Gastroenterol. 2002;97:2000–2004.PubMedCrossRef
13.
Suzuki T. Regulation of intestinal epithelial permeability by tight junctions. Cell Mol Life Sci. 2013;70:631–659.PubMedCrossRef
Metadata
Title
Intestinal Permeability Barrier in Crohn’s Disease: The Difficulty in Shifting the Paradigm
Author
Daniel Hollander
Publication date
01-07-2013
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 7/2013
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-013-2721-y

Other articles of this Issue 7/2013

Digestive Diseases and Sciences 7/2013 Go to the issue

Original Article

Use of a High Caloric Liquid Meal as an Alternative to a Solid Meal for Gastric Emptying Scintigraphy

Original Article

Backwash Ileitis and the Risk of Colon Neoplasia in Ulcerative Colitis Patients Undergoing Restorative Proctocolectomy

Editorial

Novel and Validated Approaches for Gastric Emptying Scintigraphy in Patients with Suspected Gastroparesis

Original Article

γ-Aminobutyric Acid B Receptor Improves Carbon Tetrachloride-Induced Liver Fibrosis in Rats

Original Article

Management for CBD Stone-Related Mild to Moderate Acute Cholangitis: Urgent Versus Elective ERCP

Original Article

Can the Adenoma Detection Rate Reliably Identify Low-Performing Endoscopists? Results of a Modeling Study
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits